Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel

✍ Scribed by O. Ortmann; O. Pagani; A. Jones; N. Maass; D. Noss; H. Rugo; C. van de Velde; Matti Aapro; R. Coleman

• Book ID: 116395510
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 273 KB
• Volume: 37
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2010.05.005